Adial Pharmaceuticals (ADIL) Shares Issued (2017 - 2026)
Adial Pharmaceuticals (ADIL) posted Shares Issued of $23239.0 for Q1 2026, down 50.79% sequentially from $47220.0 in Q4 2025, and down 96.86% YoY from $739999.0 in Q1 2025.
Adial Pharmaceuticals (ADIL) Shares Issued (2017 - 2026) Analysis & Trends
Adial Pharmaceuticals has reported Shares Issued for 10 years, with the latest figure at $23239.0 in Q1 2026.
- Quarterly Shares Issued fell 96.86% year-over-year to $23239.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23239.0 (down 96.86% YoY) and the FY2025 annual result came in at $47220.0, up 60.93% from the prior year.
- Shares Issued eased to $23239.0 in Q1 2026 per ADIL's latest filing, from $47220.0 in the prior quarter.
- Over five years, Shares Issued peaked at $4.3 million in Q3 2022 and troughed at $6068.0 in Q4 2023.
- A 5-year average of $1.2 million and a median of $205000.0 in 2024 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2024 and 2025: Shares Issued sank 97.12% in 2024, then surged 706.86% in 2025.
- Over 5 years, Shares Issued stood at $172676.0 in 2022, then tumbled by 96.49% to $6068.0 in 2023, then jumped by 383.55% to $29342.0 in 2024, then surged by 60.93% to $47220.0 in 2025, then sank by 50.79% to $23239.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $23239.0, $47220.0, and $406060.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Adial Pharmaceuticals | 29.02 Mn | 29.02 Mn | - | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,239.00 |
| Mar 31, 2026 | 23,239.00 |
| Dec 31, 2025 | 47,220.00 |
| Dec 31, 2025 | 47,220.00 |
| Sep 30, 2025 | 406,060.00 |
| Sep 30, 2025 | 406,060.00 |
| Jun 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 739,999.00 |
| Mar 31, 2025 | 739,999.00 |
| Dec 31, 2024 | 29,342.00 |
| Dec 31, 2024 | 29,342.00 |
| Sep 30, 2024 | 205,000.00 |
| Sep 30, 2024 | 205,000.00 |
| Jun 30, 2024 | 146,764.00 |
| Jun 30, 2024 | 146,764.00 |
| Mar 31, 2024 | 124,117.00 |
| Mar 31, 2024 | 124,117.00 |
| Dec 31, 2023 | 6,068.00 |
| Dec 31, 2023 | 6,068.00 |